L-Kynurenine

L-Kynurenine

SCHEMBL20875

Nc1ccccc1C(=O)C[C@H](N)C(=O)O

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.64
HIF1A Q16665 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
KYNU Q16719 2/20 0.49
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
ALPI P09923 1/20 0.47
PKM P14618 1/20 0.47
PTGS1 P23219 1/20 0.47
XIAP P98170 1/20 0.47
SLC7A5 Q01650 1/20 0.47
KMO O15229 3/20 0.45
SLC1A3 P43003 2/20 0.45
SLC1A2 P43004 2/20 0.45
SLC1A1 P43005 2/20 0.45
GRM2 Q14416 1/20 0.45
GRM3 Q14832 1/20 0.45
GRIK1 P39086 1/20 0.43
ALDH1A1 P00352 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Kynurenine SCHEMBL288254 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL29349989 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
L-Kynurenine SCHEMBL29396313 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
L-Kynurenine SCHEMBL29415716 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
L-Kynurenine SCHEMBL288989 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
L-Kynurenine SCHEMBL13969610 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL288988 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL20874 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL2181581 1.00 KDM4E (0.64) KDM4EHIF1ATDP1KYNUGAA
Kynurenine SCHEMBL2368792 0.98 KDM4E (0.62) KDM4EHIF1ATDP1KYNUGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 16291 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260146967-A1 DEVICE AND SENSOR FOR DETECTION OF AN ANALYTE REMINDED, INC. (US) 2026-05-28 US claimed
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP claimed
US-12633376-B2 System and method for risk assessment of autism spectrum disorder TATA CONSULTANCY SERVICES LIMITED (IN) 2026-05-19 US claimed
CN-121709269-B Method and system for monitoring psychological state of cancer patient 南通大学 2026-05-15 CN claimed
CN-122031539-A Pine bark polyphenol extract and preparation method and application thereof 北京农学院 2026-05-15 CN claimed
WO-2026100590-A1 SYSTEM FOR EVALUATING PERSON SUFFERING FROM COVID-19, METHOD FOR EVALUATING PERSON SUFFERING FROM COVID-19, AND COMPUTER PROGRAM 地方独立行政法人 神奈川県立病院機構 2026-05-15 WO claimed
EP-3869192-B1 METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE HUMAN METABOLOMICS INST INC (CN) 2026-05-13 EP claimed
US-20260120870-A1 ARTIFICIAL INTELLIGENCE-BASED INFORMATION PROVISION METHOD FOR DIAGNOSING LUNG CANCER BY USING BIOMARKER FOR LUNG CANCER DIAGNOSIS AND CLINICAL INFORMATION OF TEST SUBJECT INNOBATION BIO CO LTD (KR) 2026-04-30 US claimed
WO-2026088246-A1 METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND NTT株式会社 2026-04-30 WO claimed
WO-2026087667-A1 METHOD OF MODIFICATION OF WHEY PROTEIN AT ACIDIC PH BY REACTION WITH OXIDIZED PHENOLIC COMPOUNDS, THE MODIFIED PROTEIN COMPOSITION, AND NUTRITIONAL USES OF THE MODIFIED PROTEIN COMPOSITION ARLA FOODS AMBA (DK) 2026-04-30 WO claimed
EP-0421946-A2 3-indolepyruvic acid derivatives their method of production and therapeutic use POLIFARMA S.p.A. (IT) 1991-04-10 EP claimed
EP-0010421-B1 MIXTURE OF ANTIBIOTICS DESIGNATED BY A-21978, PROCESS FOR ITS PRODUCTION, THEIR PHARMACEUTICAL COMPOSITIONS AND PRODUCING MICROORGANISM ELI LILLY AND COMPANY (US) 1990-10-10 EP claimed
WO-1988007851-A1 LIPOSOME ENTRAPPED N-METHYL-D-ASPARTATE RECEPTOR BLOCKERS INNOVATIVE THERAPEUTICS CORPORATION (US) 1988-10-20 WO claimed
US-RE32455-E A-21978 antibiotics and process for their production ELI LILLY AND COMPANY (US) 1987-07-07 US claimed
US-4620850-A HYDROXYBENZOLFURANONE WELLA AKTIENGESELLSCHAFT (DE) 1986-11-04 US claimed
EP-0085283-A1 Pyroglutamyl-tryptophan derivatives, process for their preparation and their therapeutic applications Società Italo-Britannica L. Manetti - H. Roberts & C. (IT) 1983-08-10 EP claimed
EP-0026474-B1 COMPOSITION AND PROCESS FOR OXIDATIVE DYEING OF HAIR Wella Aktiengesellschaft (DE) 1983-06-08 EP claimed
EP-0026473-B1 OXIDATIVE HAIR-DYEING COMPOSITION Wella Aktiengesellschaft (DE) 1983-05-25 EP claimed
US-4331594-A PEPTIDE ANTIBIOTICS ELI LILLY AND COMPANY (US) 1982-05-25 US claimed
EP-0010421-A1 Mixture of antibiotics designated by A-21978, process for its production, their pharmaceutical compositions and producing microorganism ELI LILLY AND COMPANY (US) 1980-04-30 EP claimed